Lecture 50 - Paraneoplasms and Presentations of Cancer Flashcards

1
Q

what are the local Effects on Tumors and Host ?

A

○ Destruction of normal tissue by tumor

○ Space occupying effect of the tumor

Tumor Erosion of mucosa, vessel, skin, nerves (bleeding, secondary infection, perineural invasion)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the “general” Effect on Tumors and Host ?

A

○ Cachexia – Progressive loss of body fat and lean body/muscle mass
Profound weakness, anorexia, anemia

○ Hormonal Effects - -

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

when should you suspect cachexia?

A

Involuntary weight loss of > 10 % of premorbid weight

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the different kinds of hormonal effects a malignancy can induce?

A

Tumor of Endocrine tissue which normally produces a hormone

vs

paraneoplastic Syndrome – hormones/ being produced by a malignant tissue that does not normally produce those hormones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are the different categories of Paraneoplastic Syndromes?

A

Endocrinopathies

Osseous Tissue syndromes

Dermatologic

Neuromyopathies

vascular/coagulopathies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Endocrinopathies

A

Paraneoplastic Cushing Syndrome-

Hypercalcemia

Syndrome of Inappropriate ADH secretion (SIADH)

Hypoglycemia

Polycythemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Paraneoplastic Cushing Syndrome-

what is it?

what type of tumor most commonly causes it ?

Symptoms?

A

tumor producing ACTH, leading to adrenal production of Cortisol

50% produced by Lung tumors

Symptoms: Cushings – truncal obesity, fat pad, easy bruising, fatigue, depression, etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Paraneoplastic Hypercalcemia

  • Significance?
  • cause?
  • type of tumor?
  • Clinical Presentation:
  • lab findings:
A

– most common incidence and most life threatening

  • Lung cancer (that has not metastisized to the bone) that produced PTH or PTH RP leading to “leakage” of calcium from the bone

Symptoms: Confusions, weakness, lethargy, constipation

Labs: Hypercalcemia + Low/normal Serum PTH; elevated PTHRP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Paraneoplasm: Syndrome of Inappropriate ADH secretion (SIADH)

  • what is it?
  • type of tumor
  • lab findings;
  • clinical effects? potential cause of death?
A

Secretion of ectopic ADH

Small Cell Carcinoma of the Lung, intracranial tumors

Labs: Hyponatremia

Clinical :cerebral edema (death); seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Paraneoplastic Hypoglycemia

  • cause
  • type of tumor

Paraneoplastic Polycythemia
- cause

A

Hypoglycemia: ectopic tumor secretes insulin like substance
- soft tissue sarcomas, hepatocellular carcinoma

Polycythemia:
Erythropoietin secreted by tumors; can cause thrombosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Osteopathic Paraneoplastic ○ Hypertrophic Osteoarthropathy

  • type of tumor
  • Triad of symptoms
A

1-10% of patients with lung cancer

– New periosteal bone formation

– Arthritis of adjacent joints

  • new onset clubbing of the fingers (in persons without emphysema)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Dermatologic Paraneoplasm:
- Ancanthosis Nigricans

  • what is it?
  • benign causes?
  • malignant causes?
A

Gray/Black patches of verrucous hyperkeratosis, usually in the skin folds due to production of epitdermal growth factors

Benign causes: Diabetes

Malignant causes: Epidermal growth factors by Lung, gastric tumors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Paraneoplastic Neuromyopathies –

Presenations?
Causes?

A

Peripheral Neuropathies, cortical cerebellar damage

  • Eaton Lambert Syndrome (auto-antibodies produced against tumor antigen which cross react with calcium channels)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Paraneoplastic - Vascular/Coagulopathies

  • DIC (cause, and type of cancer)

NBTE (what is it?)

Trousseau Syndrome - (what is it; types/stage of cancer that causes it?)

A

DIC –
cancers: APL, Prostate cancer
Cause: Mucin with pro-coagulant effect

NBTE
- Non bacterial thrombotic endocarditis (non bacterial vegetations on the cardiac leaflets which can prduce emboli)
caused by advanced cancers

Trousseau Syndrome --
Advanced cancers (pancreas and lung); secrete mucins which activate the coagulation cascade leading to migratory (sequential) thrombophlebitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Ancillary Tests of Pathology:

IHC as diagnositic test –

A

Uses – finding the tissue of origin in met, finding micro mets

Finding an unknown primary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Ancillary Tests of Pathology:

IHC as Prognostic/predictive test –

examples of use of IHC for finding targets for treatment

A

Proliferation rate –

				Her2/neu -- if positive --- Herceptin (positive predictor, negative prognosis) 
				Hormone Receptor Status:    Estrogen Receptor of Breast Cancer (positive prognosis and predictive --- Tomoxifen, aromatase inhibitor)
17
Q

What marker is used as metric for “proliferation rate”

A

Measured by Ki-67 (MIB1)

18
Q
    • how is Flow cytometry use?

- - how is cytogenic used?

A

Flow Cytometry – mainstay Dx of leukemias, lymphomas — classify tumor cells by surface markers

Cytogenetic: Used to find chromosomal translocations, etc

19
Q

How are tumor markers utilized?

A

They can help with diagnosis of disease, but NOT SPECIFIC or SENSITIVE ENOUGH TO BE PRIMARY DIAGNOSTIC

  • can be used to correlate tumor burden
    • can be used to track remission/recurrence
20
Q

The tumors Markers to REMEMBER: which of these can also be used for screening? What are they used to track?

PSA

CEA

AFP

A

□ PSA (prostate specific antigen): prostate cancer - the only one also used for screening (But nonspecific)

□ CEA (carcino-embryonic antigen): colon, pancreas Ca

□ AFP (alpha feto protein): hepatocellular, testicular Ca

21
Q

tumor markers — what cancers?

CA-125

HCG:

CA19-9:

A

□ CA-125: ovarian tumors

□ HCG: testicular cancers

□ CA19-9: colon, pancreas Ca

22
Q

Molecular analyses of tumors:
Positive/negative predictors?

EML4-ALK fusion in lung cancer

V600E mutation of BRAF in melanoma

A

EML4-ALK fusion in lung cancer – positive predictive (ALK inhibitor Crisotinib)

□ V600E mutation of BRAF in melanoma – positive predictive (BRAF inhibitor PLX4032)

23
Q

Molecular analyses of tumors:
Positive/negative predictors?

EGFR –

Ras –

A

□ EGFR – positive predictive (Erlotinib)

□ Ras - negative prognostic and negative predictive marker (cetuximab) in colon cancer